ReviewCurrent opinion in cardiology2016
What to say and how to say it: effective communication for cardiovascular disease prevention.
Review in Current opinion in cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cardiovascular disease risk communication and prevention: a meta-analysis.European heart journal · 2024Pooled it
- Optimizing low-density lipoprotein cholesterol (LDL-C) management - a US physician survey of barriers and burdens.American journal of preventive cardiology · 2026Article
- Patients' awareness of the cardiovascular risk factors - results of the primary care arm of EUROASPIRE V study in Croatia.BMC cardiovascular disorders · 2025Article
- Risk and Safety in Radiographic Utilization: Evaluating the Evidence From Current Research.Radiology research and practice · 2025Review
- Awareness of cardiovascular risk among persons with type 2 diabetes: a qualitative study.International journal of qualitative studies on health and well-being · 2024Article
- Risk of Cardiovascular Events in Adults Aged 40 to 79 Years with Diagnosed Hypertension, High Cholesterol, and/or Diabetes but Not on Medications: Findings from Nationwide Cross-Sectional Studies.Journal of cardiovascular development and disease · 2024Article
- Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward.Current cardiology reviews · 2024Review
- [Primary and secondary prevention in hypercholesterolemia: differences relevant to patient care in the PROCYON trial].Deutsche medizinische Wochenschrift (1946) · 2023Article
- Cardiovascular disease threat and perceived efficacy of selected preventive behaviors among Polish men: an analysis based on the extended parallel process model.Frontiers in public health · 2023Article
- Patient and Physician Reported Perception on Hypercholesterolemia Management in Primary Prevention in Germany: Results from a Nationwide Online Survey.Advances in therapy · 2022Article
- Consensus-Based Development of an Assessment Tool: A Methodology for Patient Engagement in Primary Care and CPD Research.The Journal of continuing education in the health professions · 2022Article
- Perceived cardiovascular disease risk and tailored communication strategies among rural and urban community dwellers in Rwanda: a qualitative study.BMC public health · 2022Article
- Communication approaches to enhance patient motivation and adherence in cardiovascular disease prevention.Clinical cardiology · 2021Review
- Association between Big Five Personality Traits and Participation in Cardiac Rehabilitation in Japanese Patients with Cardiovascular Disease: A Retrospective Cohort Study.International journal of environmental research and public health · 2021Article
- Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy.Circulation. Cardiovascular quality and outcomes · 2021Article
- Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.Journal of the American Heart Association · 2020Article
- Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria.BMJ open diabetes research & care · 2020Article
- Life-Saving Medications: The Urgent Need for Guideline Adherence and Patient Acceptance.Journal of the American Heart Association · 2019Article
- Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles.American heart journal · 2018Article
- Physicians' perspectives on communication and decision making in clinical encounters for treatment of latent tuberculosis infection.ERJ open research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewCurrent guidelines for cholesterol treatment emphasize the importance of engaging patients in a risk-benefit discussion prior to initiating statin therapy. RECENT
findingsAlthough current risk prediction algorithms are well defined, there is less data on how to communicate with patients about cardiovascular disease risk, benefits of treatment, and possible adverse effects. SUMMARY: We propose a four-part model for effective shared decision-making: 1) Assessing patient priorities, perceived risk, and prior experience with cardiovascular risk reduction; 2) Arriving at a recommendation for therapy based on the patient's risk of disease, guideline recommendations, new clinical trial data, and patient preferences; 3) Communicating this recommendation along with risks, benefits, and alternatives to therapy following best practices for discussing numeric risk; and 4) Arriving at a shared decision with the patient with ongoing reassessment as risk factors and patient priorities change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.